Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activi...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PLOS
|
| Subjects: | |
| Online Access: | https://repository.ugm.ac.id/282460/1/202.pdf |
| _version_ | 1826050528101007360 |
|---|---|
| author | Ley, Benedikt Alam, Mohammad Shafiul Satyagraha, Ari Winasti Phru, Ching Swe Thriemer, Kamala Tadesse, Dagimawie Shibiru, Tamiru Hailu, Asrat Kibria, Mohammad Golam Hossain, Mohammad Sharif Rahmat, Hisni Poespoprodjo, Jeanne R. Khan, Wasif Ali Simpson, Julie A. Price, Ric N. |
| author_facet | Ley, Benedikt Alam, Mohammad Shafiul Satyagraha, Ari Winasti Phru, Ching Swe Thriemer, Kamala Tadesse, Dagimawie Shibiru, Tamiru Hailu, Asrat Kibria, Mohammad Golam Hossain, Mohammad Sharif Rahmat, Hisni Poespoprodjo, Jeanne R. Khan, Wasif Ali Simpson, Julie A. Price, Ric N. |
| author_sort | Ley, Benedikt |
| collection | UGM |
| description | Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium
vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of
older erythrocytes with low G6PD activity by reticulocytes and young erythrocytes with
higher activity. Aim of this study was to assess the impact of acute malaria on G6PD activity.
Selected patients with uncomplicated malaria were recruited in Bangladesh (n = 87), Indonesia (n = 75), and Ethiopia (n = 173); G6PD activity was measured at the initial presentation
with malaria and a median of 176 days later (range 140 to 998) in the absence of malaria.
Among selected participants (deficient participants preferentially enrolled in Bangladesh but
not at other sites) G6PD activity fell between malaria and follow up by 79.1% (95%CI: 40.4
to 117.8) in 6 participants classified as deficient (<30% activity), 43.7% (95%CI: 34.2 to
53.1) in 39 individuals with intermediate activity (30% to <70%), and by 4.5% (95%CI: 1.4 to
7.6) in 290 G6PD normal (�70%) participants. In Bangladesh and Indonesia G6PD activity
was significantly higher during acute malaria than when the same individuals were retested
during follow up (40.9% (95%CI: 33.4–48.1) and 7.4% (95%CI: 0.2 to 14.6) respectively),
whereas in Ethiopia G6PD activity was 3.6% (95%CI: -1.0 to -6.1) lower during acute
malaria. The change in G6PD activity was apparent in patients presenting with either
P. vivax or P. falciparum infection. Overall, 66.7% (4/6) severely deficient participants and
87.2% (34/39) with intermediate deficiency had normal activities when presenting with
malaria. These findings suggest that G6PD activity rises significantly and at clinically relevant levels during acute malaria. Prospective case-control studies are warranted to confirm the degree to which the predicted population attributable risks of drug induced haemolysis is
lower than would be predicted from cross sectional surveys. |
| first_indexed | 2024-03-14T00:05:24Z |
| format | Article |
| id | oai:generic.eprints.org:282460 |
| institution | Universiti Gadjah Mada |
| language | English |
| last_indexed | 2024-03-14T00:05:24Z |
| publisher | PLOS |
| record_format | dspace |
| spelling | oai:generic.eprints.org:2824602023-11-16T03:58:31Z https://repository.ugm.ac.id/282460/ Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria Ley, Benedikt Alam, Mohammad Shafiul Satyagraha, Ari Winasti Phru, Ching Swe Thriemer, Kamala Tadesse, Dagimawie Shibiru, Tamiru Hailu, Asrat Kibria, Mohammad Golam Hossain, Mohammad Sharif Rahmat, Hisni Poespoprodjo, Jeanne R. Khan, Wasif Ali Simpson, Julie A. Price, Ric N. Medical Parasitology Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activity by reticulocytes and young erythrocytes with higher activity. Aim of this study was to assess the impact of acute malaria on G6PD activity. Selected patients with uncomplicated malaria were recruited in Bangladesh (n = 87), Indonesia (n = 75), and Ethiopia (n = 173); G6PD activity was measured at the initial presentation with malaria and a median of 176 days later (range 140 to 998) in the absence of malaria. Among selected participants (deficient participants preferentially enrolled in Bangladesh but not at other sites) G6PD activity fell between malaria and follow up by 79.1% (95%CI: 40.4 to 117.8) in 6 participants classified as deficient (<30% activity), 43.7% (95%CI: 34.2 to 53.1) in 39 individuals with intermediate activity (30% to <70%), and by 4.5% (95%CI: 1.4 to 7.6) in 290 G6PD normal (�70%) participants. In Bangladesh and Indonesia G6PD activity was significantly higher during acute malaria than when the same individuals were retested during follow up (40.9% (95%CI: 33.4–48.1) and 7.4% (95%CI: 0.2 to 14.6) respectively), whereas in Ethiopia G6PD activity was 3.6% (95%CI: -1.0 to -6.1) lower during acute malaria. The change in G6PD activity was apparent in patients presenting with either P. vivax or P. falciparum infection. Overall, 66.7% (4/6) severely deficient participants and 87.2% (34/39) with intermediate deficiency had normal activities when presenting with malaria. These findings suggest that G6PD activity rises significantly and at clinically relevant levels during acute malaria. Prospective case-control studies are warranted to confirm the degree to which the predicted population attributable risks of drug induced haemolysis is lower than would be predicted from cross sectional surveys. PLOS Article PeerReviewed application/pdf en https://repository.ugm.ac.id/282460/1/202.pdf Ley, Benedikt and Alam, Mohammad Shafiul and Satyagraha, Ari Winasti and Phru, Ching Swe and Thriemer, Kamala and Tadesse, Dagimawie and Shibiru, Tamiru and Hailu, Asrat and Kibria, Mohammad Golam and Hossain, Mohammad Sharif and Rahmat, Hisni and Poespoprodjo, Jeanne R. and Khan, Wasif Ali and Simpson, Julie A. and Price, Ric N. Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria. PLoS Neglected Tropical Diseases, 16 (5). e0010406. ISSN 1935-2735 https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010406 10.1371/journal.pntd.0010406 |
| spellingShingle | Medical Parasitology Ley, Benedikt Alam, Mohammad Shafiul Satyagraha, Ari Winasti Phru, Ching Swe Thriemer, Kamala Tadesse, Dagimawie Shibiru, Tamiru Hailu, Asrat Kibria, Mohammad Golam Hossain, Mohammad Sharif Rahmat, Hisni Poespoprodjo, Jeanne R. Khan, Wasif Ali Simpson, Julie A. Price, Ric N. Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria |
| title | Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria |
| title_full | Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria |
| title_fullStr | Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria |
| title_full_unstemmed | Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria |
| title_short | Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria |
| title_sort | variation in glucose 6 phosphate dehydrogenase activity following acute malaria |
| topic | Medical Parasitology |
| url | https://repository.ugm.ac.id/282460/1/202.pdf |
| work_keys_str_mv | AT leybenedikt variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT alammohammadshafiul variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT satyagrahaariwinasti variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT phruchingswe variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT thriemerkamala variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT tadessedagimawie variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT shibirutamiru variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT hailuasrat variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT kibriamohammadgolam variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT hossainmohammadsharif variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT rahmathisni variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT poespoprodjojeanner variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT khanwasifali variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT simpsonjuliea variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria AT pricericn variationinglucose6phosphatedehydrogenaseactivityfollowingacutemalaria |